Cogent Biosciences (COGT) Change in Acquisitions & Divestments (2017 - 2026)

Cogent Biosciences (COGT) has 7 years of Change in Acquisitions & Divestments data on file, last reported at $97.8 million in Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments rose 39.91% year-over-year to $97.8 million in Q1 2026; TTM through Mar 2026 was $317.1 million, a 9.25% increase from a year earlier, with the FY2025 full-year figure at $289.2 million, down 1.78% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $97.8 million, up from $73.3 million in the prior quarter.
• Over the last five years, Change in Acquisitions & Divestments for COGT reached as high as $120.0 million in Q1 2023 and fell as low as $22.1 million in Q3 2023.
• Historically, Change in Acquisitions & Divestments has averaged $71.9 million across 4 years, with a median of $73.3 million in 2025.
• On a YoY basis, Change in Acquisitions & Divestments climbed as much as 262.41% in 2024 and fell as far as 38.23% in 2024.
• Year by year, Change in Acquisitions & Divestments stood at $61.7 million in 2023, then grew by 20.66% to $74.5 million in 2024, then declined by 1.62% to $73.3 million in 2025, then jumped by 33.53% to $97.8 million in 2026.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $97.8 million in Q1 2026, $73.3 million in Q4 2025, and $69.1 million in Q3 2025.